Caroline Young, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 154 shares at $1.26 ($256) on 2024-12-03, disclosed to the SEC on 2024-12-30.
Scheduled purchase ($256) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.33 | 15 | $20 | 7.8% |
| 2 | $1.26 | 15 | $19 | 7.4% |
| 3 | $1.22 | 15 | $18 | 7.1% |
| 4 | $1.20 | 15 | $18 | 7.0% |
| 5 | $1.20 | 15 | $18 | 7.0% |
| 6 | $1.25 | 15 |
| $19 |
| 7.3% |
| 7 | $2.48 | 7 | $17 | 6.8% |
| 8 | $2.29 | 7 | $16 | 6.3% |
| 9 | $2.19 | 7 | $15 | 6.0% |
| 10 | $2.33 | 7 | $16 | 6.4% |
| 11 | $2.21 | 10 | $22 | 8.6% |
| 12 | $2.12 | 10 | $21 | 8.3% |
| 13 | $2.19 | 10 | $22 | 8.5% |
| 14 | $2.33 | 4 | $9 | 3.6% |
| 15 | $2.35 | 2 | $5 | 1.8% |
| Total | $1.66 avg | 154 | $256 | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $404 | — | Filing → |
| CPIX | BUY | 2025-06-06 | $429 | — | Filing → |
| CPIX | BUY | 2025-05-09 | $417 | — | Filing → |